At the touch of a high -level American visit
Abu Dhabi, water,, July 4, 2025 / Prnewswire / – The Ministry of Health – Abu Dhabi (DOH), the regulator of the health care sector in Abu Dhabiannounced a historical partnership with the University of California, San Francisco (UCSF) and the Innovative Genomic Institute (IGI) to explore the creation of the world’s first world surgery centers Abu Dhabi And California. Formalized during a strategic visit to The United StatesCollaboration seeks to accelerate emirate’s efforts to lead in genomic medicine and advance personalized genetic therapy, transforming the future of health care for the global community.
Genome surgery is an experimental medical technique aimed at modifying or replacing defective genes in cells to treat or prevent diseases. This is done thanks to personalized genetic therapies or using advanced technologies such as CRISPR, which can be specifically adapted to each patient according to their unique genetic mutations.
These new centers would allow the diagnosis and correction of serious genetic conditions as soon as possible to improve results. Taking advantage of CRISPR technologies, the centers would offer personalized interventions guided by the genome which have the potential to transform the results of patients and to redefine the future of health care.
Dr. Noura Khamis al GhaithiUnder -secretary of the Ministry of Health – Abu Dhabicommented: “This collaboration reflects Abu Dhabi Determination for pioneer of real applications of advanced science. The partnership with UCSF and IGI, one of the most respected institutions in the world in gene therapy, would accelerate our ability to integrate the care guided by the genome in our health system, creating an unprecedented opportunity to correct the genetic conditions early in life, to prevent the progression of chronic diseases and to reduce long -term health costs “.
By combining Abu Dhabi Cuttless health care infrastructure and genomic data capacities with UCSF world leadership in pediatric and fetal therapy and IGI advanced research in genetic edition, partnership would lead to the development and delivery of innovative and real solutions for patients with severe and innovative diseases.
Doctor Tippi MackenzieDirector of the UCSF Broad Stem Cell Center, University of California, San Francisco (UCSF), said: “It is an extraordinary moment to be in medicine, when we have the possibility of developing vital therapies for patients with serious genetic conditions. We are delighted by the possibility of developing mirror programs that merge multidisciplinary expertise and link the myriad of stages between the diagnosis of a genetic disease and the development and the implementation of a strategy of surgery of the self -surgery.”
Collaboration would also favor the construction of national expertise by forming a new generation of emirati professionals in genomic surgery and clinical innovation. By intervening early in deadly or debilitating conditions, the initiative would strengthen the capacity to support families, reduce dependence on life treatments and relieve pressure on the health system, cementation Abu Dhabi Position as a global destination for advanced genomic care and life science innovation.
Dr Fyodor Urnov, professor of molecular therapy University of California, Berkeleyand director of the Igi-Danaher tag for Crispr Curessaid: “This year marks a historic realization for the science and medicine of a Crispr therapy designed and administered at the request to an infant with an innate error of metabolism in record time. The mission of the innovative genomic institute as defined by its founder, Jennifer DoudnaWinner of the Nobel Prize 2020 for the editing of the CRISPR genes, must make it the standard of medical care, it doesn’t matter where such a child was born. The deep partnership of the IGI with Danaher which made a hably contribution to the gene to the publishing request earlier this year provides a technological and exceptional manufacturing base to extend such therapeutic approaches. We are honored to associate with the advanced clinical expertise of the UCSF to explore how we can finally extend Crispr on demand to children living with serious genetic diseases to water. “”
This exploratory partnership aligns with Abu Dhabi A wider vision to integrate genomics into public health and lead to a turn towards personalized and preventive care. At the heart of this effort is the Emirati Genome program, which has led to more than 800,000 genomes to date, to create one of the most diverse national databases worldwide. The program has enabled key initiatives such as the National Pharmacogenomics Reporting System (PGX), with more than 160,000 reports now available to help adapt the treatment plans according to individual genetic profiles. Additional steps include the integration of genetic tests in the screening program before marriage, the launch of the newborn genetic screening program and the development of the Emirati reference genome platform. These efforts are supported by the bulge of more than 100 emiratis doctors in genomic medicine and advice thanks to advanced training initiatives, strengthening local expertise in this critical field.
Show the original content:https://www.prnewswire.com/apac/news-releases/doh-uscf-and-igi-extablishing–she-worlds-first-of-their-kind-foreres-for-génome-chirury-3024989.html
Source of the Ministry of Health – Abu Dhabi
